MANNKIND CORP: STATE STREET CORP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
State Street Corp. disclosed a stake exceeding 5% in MannKind Corp. via a Schedule 13G filing with the SEC (accession 0000093751-26-000688). The filing signals that the institutional investor has crossed the 5% beneficial ownership threshold in the biopharmaceutical company. The exact share count and percentage were not specified in the headline disclosure. The move matters because it places State Street among MannKind's major institutional holders, a status that can influence governance and shareholder votes. Investors will watch for the full 13G details, including precise share counts and any subsequent 13G/A amendments reflecting changes in the position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
State Street Corp, MannKind Corp